1AI 14.3% 0.6¢ algorae pharmaceuticals limited

Passing Through the 20's, page-110

  1. 12,377 Posts.
    lightbulb Created with Sketch. 6360
    Beyond 6 months highly unlikely any placebo effect as deterioration continues... Phase I Trial Patients are at over 18 months and continue to show signs of improvement.
    Phase I, 40 capsules , single side of the brain, "Carol"....
    Phase II , Group 1 40 Both sides total 80 micro capsules, Group 2 80 Both side, 160 micro capsules, Group 3 120 Both Sides 240 micro capsules. With a greater positive response to NTCELL you diminish and reduce the Placebo Effect.
    ie 3 Trial Patients from each group have improved demonstrably above the 4th Placebo Patient.
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
0.6¢
Change
-0.001(14.3%)
Mkt cap ! $10.12M
Open High Low Value Volume
0.6¢ 0.6¢ 0.6¢ $477 79.44K

Buyers (Bids)

No. Vol. Price($)
16 6813716 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 20556 1
View Market Depth
Last trade - 15.34pm 01/11/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.